Combination therapies in the treatment of osteoporosis
Combination therapies in the treatment of osteoporosis
Combination therapies in the treatment of osteoporosis
Bone. 2019 Dec;129:115048. doi:10.1016/j.bone.2019.115048 Polyzos SA, Makras P, Tournis S, Anastasilakis AD
J Womens Health (Larchmt). 2019 Dec 31. doi:10.1089/jwh.2019.7828. Salagame U, Kliewer EV, Demers A, Banks E, Velentzis LS, Goldsbury D, Egger S,Leslie WD, Canfell K.
J Bone Miner Res. 2019 Dec 30. doi: 10.1002/jbmr.3947. Schepper JD, Collins F, Rios-Arce ND, Kang HJ, Schaefer L, Gardinier JD,Raghuvanshi R, Quinn RA, Britton R, Parameswaran N, McCabe LR.
Noncoding RNA miR-205-5p mediates osteoporosis pathogenesis and osteoblast differentiation by regulating RUNX2
Changes in vascular calcification and bone mineral density in calcium supplement users from the Canadian Multi-center Osteoporosis Study (CaMOS)
Treating osteoporotic osteoarthritis, or the art of cutting a balding man’s hair
3D culture modelling: An emerging approach for Translational Cancer Research in Sarcomas
Osteopenia and Osteoporosis in Patients with Bronchiectasis: Association with Respiratory Parameters, Body Composition, Muscle Strength and Bone Remodeling Biomarkers.
Psychotropic medications and proton pump inhibitors and the risk of fractures in the teriparatide versus risedronate VERO clinical trial.